Ticker
ACRVCompany Name
ACRIVON THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Dividends & Other Cash Distributions | Payout Yield |
---|---|---|---|---|
6/30/2025 | $ 41.21M | $ 1K | $ 0 | 0% |
3/31/2025 | $ 35.75M | $ 130.01M | $ 0 | -363.72% |
12/31/2024 | $ 79.01M | $ 130.09M | $ 0 | -164.66% |
9/30/2024 | $ 246.91M | $ 130.41M | $ 0 | -52.82% |
6/30/2024 | $ 224.55M | $ 130.49M | $ 0 | -58.11% |
3/31/2024 | $ 258.13M | $ 854K | $ 0 | -0.33% |
12/31/2023 | $ 161.85M | $ 775K | $ 0 | -0.48% |
9/30/2023 | $ 101.87M | $ 102.14M | $ 0 | -100.27% |
6/30/2023 | $ 273.48M | $ 102.09M | $ 0 | -37.33% |
3/31/2023 | $ 297.54M | $ 0 | $ 0 | 0% |
(-1 * CF - Equity -1 * CF - Dividends) / Market Cap
(=) Payout Yield
Payout Yield for ACRIVON THERAPEUTICS INC is calculated as follows: (-1 * CF - Equity [ $ 1K ] -1 * CF - Dividends [ $ 0 ]) / Market Cap [ $ 0 ]
(=) Payout Yield [ 0% ]
Minimum
Mar 31, 2025
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 3.53K |
---|---|
min | -15.69% |
max | 16.92% |
average | 1.82% |
median | 1.33% |
std | 5.1% |